Tumor Embolization Devices Global Market Report 2025

Description

Tumor embolization devices are minimally invasive instruments employed in the treatment of tumors. These devices serve the purpose of either occluding the blood supply to the tumor or delivering therapeutic agents directly to the tumor site.

The primary categories of tumor embolization devices include radioembolic agents and non-radioactive embolic agents. Non-radioactive embolic agents encompass materials like gelatin foam, tris-acryl gelatin microspheres, and polyvinyl alcohol (PVA) that are utilized in the treatment of tumors. These applications are relevant to both cancerous and noncancerous tumors, and the devices are employed by various end-users, including hospitals, cancer treatment centers, intensive care units, and surgical centers.

The tumor embolization devices market research report is one of a series of new reports from The Business Research Company that provides tumor embolization devices market statistics, including tumor embolization devices industry global market size, regional shares, competitors with a tumor embolization devices market share, detailed tumor embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor embolization devices industry. This tumor embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor embolization devices market size has grown strongly in recent years. It will grow from $1493.6 billion in 2024 to $1600.57 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.

The tumor embolization devices market size is expected to see strong growth in the next few years. It will grow to $2286.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.

The increasing global prevalence of cancer is expected to drive the growth of the tumor embolization devices market during the forecast period. For example, in October 2022, Macmillan Cancer Support, the largest healthcare charity in the UK, projected that the number of cancer cases would reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising cancer incidence worldwide is likely to fuel the demand for tumor embolization devices in the coming years.

The growth in healthcare expenditures is set to drive the tumor embolization devices market. Healthcare expenditures include all costs related to providing healthcare services, such as family planning, nutrition programs, and emergency health assistance. Increased spending in healthcare facilitates the development of various health-related products, including tumor embolization devices. For instance, according to economic forecasts from the Office for Budget Responsibility (OBR) and the Treasury, a UK-based non-departmental public body, the UK's health spending is expected to rise to £192 billion ($244.43 billion) in 2024/25, compared to £182 billion ($231.70 billion) in 2022/23. Thus, the increase in healthcare expenditures is a key factor driving the growth of the tumor embolization devices market.

Key players in the tumor embolization devices market are developing innovative products, such as angiography systems, to improve the accuracy and effectiveness of tumor-targeted treatments. Angiography systems are specialized imaging tools used to visualize blood vessels and evaluate blood flow within the body. For example, in June 2022, Siemens Healthineers, a Germany-based healthcare company, introduced the Artis Icono Ceiling. This ceiling-mounted angiography system is designed to enhance precision in tumor embolization and other interventional procedures. The Artis Icono Ceiling features rapid three-dimensional (3D) data acquisition, capturing images at the patient's head in just 2.5 seconds and from the sides in 4 seconds. This minimizes motion artifacts and reduces the need for contrast media. The system is versatile, making it suitable for various specialties, including interventional radiology and cardiology.

Major companies in the tumor embolization devices market are emphasizing the introduction of innovative treatments, such as Eye90, to maximize market revenue. Eye90 microspheres are a Y90 radioembolization device specifically designed for the treatment of liver tumors, particularly hepatocellular carcinoma. In May 2023, ABK Biomedical, a Canada-based medical device company, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a multicenter pivotal study of Eye90 microspheres in hepatocellular carcinoma. These microspheres are produced through a proprietary manufacturing process, resulting in uniform size distribution and high radioactivity concentration. They are designed to deliver a high dose of radiation to the tumor while minimizing exposure to healthy tissue.

In August 2022, Boston Scientific, a US-based medical device manufacturer, acquired Obsidio Inc. to strengthen its portfolio in interventional oncology and embolization. Obsidio is a US-based developer of embolization gel.

Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor embolization devices market consists of sales of radioembolic agents and non-radioactive embolic agents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents
2) By Application: Cancer Tumors; Noncancerous Tumors
3) By End User: Hospitals; Cancer Treatment Centers; Intensive Care Units; Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres; Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs); Microspheres (Polyvinyl Alcohol - PVA Particles); Gelatin Sponges; Liquid Embolic Agents (Onyx, Glue-Based Agents)
Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Terumo Corporation; Sirtex Medical Limited; Merit Medical Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r32828

1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Trends And Strategies

4. Tumor Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Embolization Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Tumor Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tumor Embolization Devices Market Growth Rate Analysis
5.4. Global Tumor Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tumor Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tumor Embolization Devices Total Addressable Market (TAM)

6. Tumor Embolization Devices Market Segmentation

6.1. Global Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radioembolic Agents
Non-radioactive Embolic Agents
6.2. Global Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Tumors
Noncancerous Tumors
6.3. Global Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Treatment Centers
Intensive Care Units
Surgical Centers
6.4. Global Tumor Embolization Devices Market, Sub-Segmentation Of Radioembolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Yttrium-90 (Y-90) Microspheres
Holmium-166 Microspheres
6.5. Global Tumor Embolization Devices Market, Sub-Segmentation Of Non-radioactive Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Eluting Beads (DEBs)
Microspheres (Polyvinyl Alcohol - PVA Particles)
Gelatin Sponges
Liquid Embolic Agents (Onyx, Glue-Based Agents)

7. Tumor Embolization Devices Market Regional And Country Analysis

7.1. Global Tumor Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tumor Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Embolization Devices Market

8.1. Asia-Pacific Tumor Embolization Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Embolization Devices Market

9.1. China Tumor Embolization Devices Market Overview
9.2. China Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Embolization Devices Market

10.1. India Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Embolization Devices Market

11.1. Japan Tumor Embolization Devices Market Overview
11.2. Japan Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Embolization Devices Market

12.1. Australia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Embolization Devices Market

13.1. Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Embolization Devices Market

14.1. South Korea Tumor Embolization Devices Market Overview
14.2. South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Embolization Devices Market

15.1. Western Europe Tumor Embolization Devices Market Overview
15.2. Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Embolization Devices Market

16.1. UK Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Embolization Devices Market

17.1. Germany Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Embolization Devices Market

18.1. France Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Embolization Devices Market

19.1. Italy Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Embolization Devices Market

20.1. Spain Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Embolization Devices Market

21.1. Eastern Europe Tumor Embolization Devices Market Overview
21.2. Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Embolization Devices Market

22.1. Russia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Embolization Devices Market

23.1. North America Tumor Embolization Devices Market Overview
23.2. North America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Embolization Devices Market

24.1. USA Tumor Embolization Devices Market Overview
24.2. USA Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Embolization Devices Market

25.1. Canada Tumor Embolization Devices Market Overview
25.2. Canada Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Embolization Devices Market

26.1. South America Tumor Embolization Devices Market Overview
26.2. South America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Embolization Devices Market

27.1. Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Embolization Devices Market

28.1. Middle East Tumor Embolization Devices Market Overview
28.2. Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Embolization Devices Market

29.1. Africa Tumor Embolization Devices Market Overview
29.2. Africa Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Embolization Devices Market Competitive Landscape And Company Profiles

30.1. Tumor Embolization Devices Market Competitive Landscape
30.2. Tumor Embolization Devices Market Company Profiles
- 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Embolization Devices Market Other Major And Innovative Companies

31.1. Cook Medical LLC
31.2. AngioDynamics Inc.
31.3. Siemens Healthineers AG
31.4. Johnson & Johnson
31.5. Penumbra Inc.
31.6. Teleflex Incorporated
31.7. Meril Life Sciences Pvt. Ltd.
31.8. Kaneka Corporation
31.9. Imagion Biosystems Ltd.
31.10. Guerbet
31.11. BTI Biotechnology Institute S.L.
31.12. BTG International
31.13. Avinger Inc.
31.14. Shape Memory Medical Inc.
31.15. Delcath Systems Inc.

32. Global Tumor Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Embolization Devices Market

34. Recent Developments In The Tumor Embolization Devices Market

35. Tumor Embolization Devices Market High Potential Countries, Segments and Strategies

35.1 Tumor Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
35.2 Tumor Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
35.3 Tumor Embolization Devices Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer